Wells Fargo
HZNP

Wells Fargo’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wells Fargo’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,800
Closed -$2.03M – 7929
2022
Q4 		$2.03M Buy
+17,800
New +$1.48M ﹤0.01% 2774

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wells Fargo's HZNP Position: Q4 2023 in Review

Wells Fargo sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 43,803 shares — an estimated $5.07M sold.

Wells Fargo first reported a position in HZNP in Q1 2014 and held it in 39 quarters. The position peaked at $206M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Wells Fargo reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Wells Fargo sold 43,803 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.07M.
  • Wells Fargo first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 39 quarters.
  • Wells Fargo's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $206M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.